The company's quarterly revenue from operations climbed 112.4% year-on-year to ₹208.6 crore, while profit after tax jumped 179.7% to ₹53.9 crore. Operational performance was bolstered by ₹867.3 crore in fresh orders won during the second quarter, bringing the total order book to ₹2,711.2 crore. To support ongoing momentum, management is targeting ₹950 crore in full-year FY27 revenue, backed by a brownfield expansion at its Gangol facility. Following the post-earnings stock jump, market analyst Gaurav Arora noted ₹1,100 as key support and ₹1,208 as resistance.
Key points
Management reaffirmed its confidence in achieving a full-year FY27 revenue target of appr…: Management reaffirmed its confidence in achieving a full-year FY27 revenue target of approximately ₹950 crore.
Long-term capacity is expected to expand with the planned commissioning of the Gangol fac…: Long-term capacity is expected to expand with the planned commissioning of the Gangol facility by FY29.
Investors should track key technical levels at ₹1,100 support and ₹1,208 resistance follo…: Investors should track key technical levels at ₹1,100 support and ₹1,208 resistance following the recent post-debut rally.
Sources checked by our analysis pipeline: 1
Kanohar Electricals shares surged over 17% on Tuesday, 3 November, after the company reported a strong set of Q2 FY27 results, with revenue and profitability registering robust year-on-year growth.
The company’s revenue from operations more than doubled, rising 112.4% year-on-year to ₹208.6 crore in Q2 FY27, compared with ₹98.2 crore in the corresponding quarter last year.
EBITDA jumped 167.2% to ₹73.1 crore from ₹27.4 crore, while the EBITDA margin expanded to 35% from 27.8% a year ago. Profit before tax (PBT) increased 178.7% to ₹72.3 crore, compared with ₹25.9 crore in Q2 FY26. Profit after tax (PAT) surged 179.7% to ₹53.9 crore from ₹19.3 crore, with the PAT margin improving to 25.8% from 19.6%.
For the first half of FY27, revenue from operations grew 108.8% year-on-year to ₹345.7 crore, compared with ₹165.6 crore in H1 FY26.
EBITDA increased 161.7% to ₹111.8 crore from ₹42.7 crore, while the EBITDA margin improved to 32.3% from 25.8%. PBT rose 162% to ₹109.1 crore, against ₹41.6 crore in the year-ago period. PAT more than doubled, increasing 164.8% to ₹81.2 crore from ₹30.7 crore.
The consumer goods company capitalized on a steep drop in raw material costs to deliver its fastest operating profit surge in over a decade. This margin expansion allowed management to dramatically lift marketing investments and pull forward long-term revenue targets. However, mixed product volumes and lingering geopolitical and commodity risks will test the durability of this operational rebound.
Under the terms being finalized, the Swiss healthcare manufacturing group is preparing to take ownership of multiple domestic facilities from the German science and technology firm. This operational transition shifts direct oversight of several key production hubs to an expanding contract development partner. The transaction directly alters the footprint of both pharmaceutical corporations across the North American market.
Steve Smith has urged controlling owner Gordon Brothers to reconsider a rejected rescue deal from Martin Property Group before the chain's creditor protection expires on November 12. A total collapse threatens far more than direct store staff, as suppliers hold back deliveries and surrounding high streets face the loss of millions of regular visitors. Government officials are also stepping in to examine the broader economic fallout of a potential liquidation.